ReviewTranslational oncology2026

Adaptive therapy for perioperative non-small cell lung cancer: strategies guided by dynamic minimal residual disease adjustment.

Li-Jin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.